Wanko Sam O, Telen Marilyn J
Duke University Medical Center, DUMC Box 3841, Durham, NC 27710, USA.
Hematol Oncol Clin North Am. 2005 Oct;19(5):803-26, v-vi. doi: 10.1016/j.hoc.2005.07.002.
Sickle cell disease (SCD) is the most commonly inherited hemoglobinopathy in the United States. Blood transfusion is a critical part of the multidisciplinary approach necessary in the management of SCD; however, blood transfusions are not without complications. The successful use of transfusion as a treatment strategy in SCD requires the critical review and knowledge of transfusion methods, generally accepted indications, clinical situations in which transfusion generally is not considered, the selection of blood products, and strategies to prevent transfusion-related complications.
镰状细胞病(SCD)是美国最常见的遗传性血红蛋白病。输血是SCD治疗多学科方法的关键组成部分;然而,输血并非没有并发症。成功地将输血作为SCD的治疗策略需要对输血方法、普遍接受的适应症、一般不考虑输血的临床情况、血液制品的选择以及预防输血相关并发症的策略进行严格审查并有所了解。